You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ara-c

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Aachen, NRW, Germany
  • +2 more
Mar 29, 2023

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)

Not yet recruiting
  • Thrombotic Disorder
  • (no location specified)
Jun 8, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Primary CNS Lymphoma (PCNSL) Trial in Zhengzhou (HD-MTX-Ara-C regimen, FTD regimen)

    Completed
    • Primary CNS Lymphoma (PCNSL)
    • HD-MTX-Ara-C regimen
    • FTD regimen
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    Mar 2, 2022

    Leukemia Trial in Tianjin (DNR:, Ara-c)

    Completed
    Has Results
    • Leukemia
    • Tianjin, Tianjin, China
    • +1 more
    Aug 8, 2021

    Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

    Completed
    Has Results
    • Diffuse Large Cell Lymphoma Relapsed/Refractory
    • San Francisco, California
      University of California, San Francisco
    Jun 5, 2022

    Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Milano, Lombardia, Italy
      Ospedale San Raffaele
    Jul 18, 2022

    Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)

    Not yet recruiting
    • Leukemia, Juvenile Myelomonocytic
    • +4 more
    • (no location specified)
    May 4, 2023

    Lymphoma Trial in Houston (AMG 531, Rituximab, Cyclophosphamide)

    Completed
    Has Results
    • Lymphoma
    • AMG 531
    • +8 more
    • Houston, Texas
      UT MD Anderson Cancer Center
    Aug 25, 2021

    Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • Taiyuan, Shanxi, China
      Tao Wang
    Feb 9, 2023

    Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

    Not yet recruiting
    • Leukemia, Acute Myeloid (AML)
    • (no location specified)
    Oct 16, 2022

    Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 21, 2023

    Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Gilteritinib 40 MG Oral Tablet
    • +4 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 27, 2022

    Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Frankfurt am Main, Hannover, Hamburg (Selinexor, Idarubicin, Cytarabine)

    Completed
    Has Results
    • Acute Myeloid Leukemia (Relapsed/Refractory)
    • Frankfurt am Main, Hessen, Germany
    • +2 more
    Aug 1, 2021

    Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

    Not yet recruiting
    • Lymphoblastic Leukemia in Children
    • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
    • +7 more
    • (no location specified)
    Oct 24, 2023

    CNS Lymphoma Trial in Aarhus (Immunochemo)

    Completed
    • Central Nervous System Lymphoma
    • Aarhus, Denmark
      Elisa Jacobsen Pulczynski
    Aug 3, 2022

    Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)

    Active, not recruiting
    Has Results
    • Acute Myeloid Leukemia
    • Nagoya, Aichi, Japan
    • +8 more
    Jan 12, 2022

    Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

    Recruiting
    • Hematological Malignancy
    • Ningbo, Zhejiang, China
      The Affiliated People's Hospital of Ningbo University.
    Aug 18, 2022

    Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

    Terminated
    Has Results
    • Leukemia
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Dec 13, 2022

    Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

    Completed
    • Leukemia
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Sep 30, 2022

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Bisantrene Dihydrochloride (high dose)
    • +3 more
    • Newcastle, New South Wales, Australia
      Calvary Mater
    Jul 14, 2022

    Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Biospecimen Collection
    • +5 more
    • Buffalo, New York
    • +1 more
    Jan 27, 2023

    Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

    Recruiting
    • Acute Myeloid Leukemia
    • Lanzhou, Gansu, China
      Long Zhao
    Apr 24, 2022

    Acute Leukemia, in Relapse, Acute Leukemia Refractory Trial in Suzhou (CVA regimen bridging to HSCT)

    Recruiting
    • Acute Leukemia, in Relapse
    • Acute Leukemia Refractory
    • CVA regimen bridging to HSCT
    • Suzhou, Jiangsu, China
      The First Affliated Hospital of Soochow University
    Jan 4, 2022